please supply a category in the pcf properties

TTUHSC’s Jansen Receives NIH Grant to Continue Study into Neurological Disorders

To continue her research, the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes for Health (NIH) recently awarded Michaela Jansen, Pharm.D., Ph.D., a four-year, $1.53 million grant.

NIH Awards Grant to TTUHSC Researcher

To better understand the role of extracellular vesicles in the spread and progression of LAM, the NIH recently awarded a four-year, $2.8 million grant to Magdalena Karbowniczek, M.D., Ph.D., a professor of immunotherapeutics and biotechnology at the TTUHSC Jerry H. Hodge School of Pharmacy.

TTUHSC Researchers Receive New NIH Grant to Continue Studying Amygdala-Pain Link

The National Institutes of Health (NIH) recently awarded a five-year, $2.76 million grant to Volker E. Neugebauer, M.D., Ph.D. and Igor Ponomarev, Ph.D.

TTUHSC Scientist Seeking Solution to Antibiotic Resistance

A team of researchers led by Hongjun (Henry) Liang, Ph.D., from the Texas Tech University Health Sciences Center (TTUHSC) Department of Cell Physiology and Molecular Biophysics, recently investigated whether or not a series of novel nanoparticles can kill some of the pathogens that lead to human infection without affecting healthy cells.

TTUHSC Researchers Receive Patent for Identifying Viable Embryos

The Texas Tech Office of Research Commercialization (ORC) filed an initial U.S. patent application in 2016, and a patent was awarded to Prien and Penrose on Nov. 8, 2021.

TTUHSC Researcher Investigates Ways to Enhance Neurolysin Activity in the Brain

Vardan Karamyan, Ph.D., in a recent collaborative study, continues his previous work evaluating the potential of Nln as a therapeutic target for stroke by seeking to identify small molecules capable of enhancing the activity and catalytic efficiency of Nln.

TTUHSC Technology Leads Successful Clinical Trial to Treat Dry Eye Disease

Hironmoy Das, Ph.D., a professor of pharmaceutical sciences at the Texas Tech University Health Sciences Center (TTUHSC) Jerry H. Hodge School of Pharmacy, developed a technology derived from corneal epithelial stem cells to improve outcomes for DED patients.

Study Could Lead to New Treatments for Neuroblastoma

In previous research, a team of investigators led by C. Patrick Reynolds, M.D., Ph.D., director of the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine Cancer Center, began studying the potential for using the ways cancer cells maintain telomeres — the protective caps on the end of chromosomes — to attack certain cancer cells.

Study of CVD Risk Factors on Cognitive Dysfunction in Elderly Rural West Texans Presented in Journal of Alzheimer’s Disease Reports

A team of researchers led by P. Hemachandra Reddy, Ph.D., professor of internal medicine, neurology and neuroscience at the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine and Hafiz Khan, Ph.D., professor for the Julia Jones Matthews Department of Public Health at the TTUHSC Graduate School of Biomedical Sciences, completed a study to better understand the risk factors for cardiovascular disease (CVD), dementia and Alzheimer’s disease in a rural population.

TTUHSC Study: Pandemic, Restrictions Have Increased Mental Health Risks for Nursing Home Caregivers

Ashish Sarangi, M.D., recently conducted research into the mental health consequences of COVID-19 geriatric care in a nursing home setting. His research, “A Descriptive Study Evaluating the Impact of COVID-19 on Delivery of Care and Mental Health of Geriatric Nursing Home Staff,” was published in the April issue of the American Journal of Geriatric Psychiatry.

Tags